Singapore

TraceTogether works by exchanging short-distance Bluetooth signals between phones to detect other participating TraceTogether users in close proximity.  

AIA Singapore, which is part of the largest public listed pan-Asian life insurance group, announced that will cover the costs of 50,000 video medical consultations provided by WhiteCoat, a Singapore-based tele-medicine provider for all its HealthShield Gold Max policyholders.

The new approach avoids malformations that are common in conventional methods, which produce particles that are ovoid in shape and result in poor flowability during manufacturing of medicines.

With the authorization by HSA, the VereCoV Detection Kit can be used directly by laboratories or hospitals to test patients for clinical diagnosis as an in-vitro diagnostic product (IVD).

iThermo reduces the need for manual temperature screening, and provides prompts where secondary checks can be carried out for feverish persons identified by the solution.

According to a paper titled Pain Management in the Elderly Population: A Review published in The Ochsner Journal in 2010, pain may be underreported because some elderly patients incorrectly believe that pain is a normal process of aging.

A group of researchers led by Assistant Professor Shao Huilin at the Institute for Health Innovation & Technology (iHealthtech) located at the National University of Singapore (NUS) is working on the development of a rapid Wuhan novel coronavirus (2019-nCoV) detection kit, based on the enVision technology platform which they invented in 2018.

Singapore-headquartered digital health startup Gmedes announced the launch of G-MEDS, a clinic app service that allows clinics to electronically prescribe, bill, dispense and deliver routine medication directly to the homes and offices of patients or their caregivers.

MicroRNA (MiRNA) is a small RNA molecule that play a central part in the functioning of the human body and are promising markers for identifying the early-stage risk of diseases such as cancer.

According to a recent BT report, the VereCoV detection kit is expected to be commercially available by Feb 1 this year.